Evaluation of Early Onset Sepsis, Complete Blood Count, and Antibiotic Use in Gastroschisis
09 June 2017
20 September 2017
30 October 2017 (eFirst)
Objective Gastroschisis is a congenital defect in which the abdominal viscera herniate through the abdominal wall. In this population, antibiotics are often initiated immediately following delivery; however, this may be unnecessary as infections typically develop as a consequence of chronic issues in gastroschisis. The objective of this study was to evaluate the incidence of culture positive early onset sepsis, the reliability of the immature to mature neutrophil count (I:T) ratio as an infectious biomarker, and antibiotic use in infants with gastroschisis.
Study Design This retrospective chart review analyzed clinical data from 103 infants with gastroschisis and 103 weight-matched controls that were evaluated for early onset infection.
Results Compared with the control group, there was a significantly increased percentage of infants with an I:T ratio > 0.2 in the gastroschisis group (43% vs. 12%, p < 0.001) and an increased percentage of infants exposed to greater than 5 days of antibiotics regardless of their I:T ratio (75% vs. 6%, p < 0.001). There were no episodes of culture positive early onset sepsis in either group.
Conclusion Our results indicate that I:T ratio is not a reliable marker of infection in gastroschisis, and suggest that empiric septic evaluation and antibiotic use, immediately following delivery in gastroschisis infants, may be unnecessary.
- 1 Lund CH, Bauer K, Berrios M. Gastroschisis: incidence, complications, and clinical management in the neonatal intensive care unit. J Perinat Neonatal Nurs 2007; 21 (01) 63-68
- 2 Baerg J, Kaban G, Tonita J, Pahwa P, Reid D. Gastroschisis: A sixteen-year review. J Pediatr Surg 2003; 38 (05) 771-774
- 3 Reid KP, Dickinson JE, Doherty DA. The epidemiologic incidence of congenital gastroschisis in Western Australia. Am J Obstet Gynecol 2003; 189 (03) 764-768
- 4 Benjamin BG, Ethen MK, Van Hook CL, Myers CA, Canfield MA. Gastroschisis prevalence in Texas 1999-2003. Birth Defects Res A Clin Mol Teratol 2010; 88 (03) 178-185
- 5 Vu LT, Nobuhara KK, Laurent C, Shaw GM. Increasing prevalence of gastroschisis: population-based study in California. J Pediatr 2008; 152 (06) 807-811
- 6 Laughon M, Meyer R, Bose C. , et al. Rising birth prevalence of gastroschisis. J Perinatol 2003; 23 (04) 291-293
- 7 Kazaura MR, Lie RT, Irgens LM. , et al. Increasing risk of gastroschisis in Norway: an age-period-cohort analysis. Am J Epidemiol 2004; 159 (04) 358-363
- 8 Hougland KT, Hanna AM, Meyers R, Null D. Increasing prevalence of gastroschisis in Utah. J Pediatr Surg 2005; 40 (03) 535-540
- 9 Loane M, Dolk H, Bradbury I. ; EUROCAT Working Group. Increasing prevalence of gastroschisis in Europe 1980-2002: a phenomenon restricted to younger mothers?. Paediatr Perinat Epidemiol 2007; 21 (04) 363-369
- 10 Sangkhathat S, Patrapinyokul S, Chiengkriwate P, Chanvitan P, Janjindamai W, Dissaneevate S. Infectious complications in infants with gastroschisis: an 11-year review from a referral hospital in southern Thailand. J Pediatr Surg 2008; 43 (03) 473-478
- 11 Chabra S. Management of Gastroschisis. NeoReviews 2006; 7 (08) e419-e427
- 12 Baird R, Puligandla P, Skarsgard E, Laberge JM. ; Canadian Pediatric Surgical Network. Infectious complications in the management of gastroschisis. Pediatr Surg Int 2012; 28 (04) 399-404
- 13 Tzialla C, Borghesi A, Perotti GF, Garofoli F, Manzoni P, Stronati M. Use and misuse of antibiotics in the neonatal intensive care unit. J Matern Fetal Neonatal Med 2012; 25 (04) (Suppl. 04) 35-37
- 14 Clark RH, Bloom BT, Spitzer AR, Gerstmann DR. Empiric use of ampicillin and cefotaxime, compared with ampicillin and gentamicin, for neonates at risk for sepsis is associated with an increased risk of neonatal death. Pediatrics 2006; 117 (01) 67-74
- 15 Cotten CM, Taylor S, Stoll B. , et al; NICHD Neonatal Research Network. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants. Pediatrics 2009; 123 (01) 58-66
- 16 Kuppala VS, Meinzen-Derr J, Morrow AL, Schibler KR. Prolonged initial empirical antibiotic treatment is associated with adverse outcomes in premature infants. J Pediatr 2011; 159 (05) 720-725
- 17 de Man P, Verhoeven BA, Verbrugh HA, Vos MC, van den Anker JN. An antibiotic policy to prevent emergence of resistant bacilli. Lancet 2000; 355 (9208): 973-978
- 18 Arboleya S, Sánchez B, Milani C. , et al. Intestinal microbiota development in preterm neonates and effect of perinatal antibiotics. J Pediatr 2015; 166 (03) 538-544
- 19 Saiman L, Ludington E, Dawson JD. , et al; National Epidemiology of Mycoses Study Group. Risk factors for Candida species colonization of neonatal intensive care unit patients. Pediatr Infect Dis J 2001; 20 (12) 1119-1124
- 20 Molik KA, Gingalewski CA, West KW. , et al. Gastroschisis: a plea for risk categorization. J Pediatr Surg 2001; 36 (01) 51-55
- 21 Schlueter RK, Azarow KS, Hines AG. , et al. Identifying strategies to decrease infectious complications of gastroschisis repair. J Pediatr Surg 2015; 50 (01) 98-101
- 22 Ramadan G, Rex D, Okoye B, Kennea NL. Early high C-reactive protein in infants with open abdominal wall defects does not predict sepsis or adverse outcome. Acta Paediatr 2010; 99 (01) 126-130